{"symbol":"AMGN","fiscalQuarter":"Q4-2012","reportDate":"2013-01-23","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2012","postBrief":{"headline":"Amgen Misses on EPS, Stock Down 0.26%","keyNumbers":[{"metric":"EPS","actual":"$1.40","expected":"N/A","surprise":"-1.96%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on cost management and operational efficiency."],"summary":"Overall, management expressed caution regarding current market conditions. They are prioritizing cost control while navigating challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report showed a slight miss on EPS, which contributed to a modest decline in the stock price. Investors may be concerned about the lack of guidance and the challenges mentioned by management. The stock's reaction reflects a cautious sentiment in the market as the company navigates these issues.","metaDescription":"Amgen Inc (AMGN) Q4 2012 earnings: EPS missed expectations. Stock down 0.26%. Full breakdown."}}